Mainstream Sleep Tracking Devices vs Polysomnography

Sponsor
NYU Langone Health (Other)
Overall Status
Withdrawn
CT.gov ID
NCT02744235
Collaborator
(none)
0
1
1
13
0

Study Details

Study Description

Brief Summary

The purpose of this study is to compare two popular portable sleep monitoring devices-the Fitbit Charge®, Jawbone UP®, and SleepTime smartphone app-to the "gold standard" Polysomnography (PSG). Parameters that will be analyzed include sleep onset latency, sleep efficiency, and sleep staging. Specifically, this study will investigate the validity of the Jawbone UP®, Fitbit Charge®, and SleepTime app in detecting sleep and wakefulness in comparison to conventional Polysomnography (PSG).

Condition or Disease Intervention/Treatment Phase
  • Device: Polysomnography Data
  • Device: Jawbone UP®
  • Device: Fitbit Charge ®
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Sensitivity and Specificity of Mainstream Sleep Tracking Devices Compared to Polysomnography
Actual Study Start Date :
Mar 1, 2016
Actual Primary Completion Date :
Apr 1, 2017
Actual Study Completion Date :
Apr 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Other: Patients undergoing Polysomnography

Device: Polysomnography Data

Device: Jawbone UP®

Device: Fitbit Charge ®

Outcome Measures

Primary Outcome Measures

  1. Time it takes subject to fall asleep [Up to 3 Months]

  2. Number of Minutes of Sleep [Up to 3 Months]

  3. Number of Arousals [Up to 3 Months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients undergoing Polysomnography
Exclusion Criteria:
  • severe sleep apnea

  • severe insomnia with less than two hours of sleep per night

  • epileptiform activity

  • electrical status epilepticus of sleep

Contacts and Locations

Locations

Site City State Country Postal Code
1 New York University School of Medicine New York New York United States 10016

Sponsors and Collaborators

  • NYU Langone Health

Investigators

  • Principal Investigator: Alcibiades Rodriguez, New York University Medical School

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
NYU Langone Health
ClinicalTrials.gov Identifier:
NCT02744235
Other Study ID Numbers:
  • 15-00071
First Posted:
Apr 20, 2016
Last Update Posted:
Apr 27, 2017
Last Verified:
Apr 1, 2017

Study Results

No Results Posted as of Apr 27, 2017